Veno Occlusive Disease News and Research

RSS
Second-quarter fiscal 2009 results announced by Gentium

Second-quarter fiscal 2009 results announced by Gentium

Gentium reports results from phase 3 trial of defibrotide for severe veno-occlusive disease

Gentium reports results from phase 3 trial of defibrotide for severe veno-occlusive disease

Gentium S.p.A. updates on phase 3 trial of Defibrotide for severe veno-occlusive disease

Gentium S.p.A. updates on phase 3 trial of Defibrotide for severe veno-occlusive disease